These newer treatments , including Semaglutide , belong to a group of drugs called GLP-1 agents. Primarily developed for treating high blood sugar, they work by encouraging the pancreas to produce more the hormone insulin and curbing increased sugar levels. Beyond diabetes, their ability to encourage weight loss has resulted to substantial attentio